Tiziana rethinks oral antibody trial amid feasibility problems ntaylor Mon, 02/07/2022 – 05:57 More: Tiziana rethinks oral antibody trial amid feasibility problems Source: fierce
read moreMoffitt Dyves back into tumor pH modulation, turning to transdermal delivery to bypass oral barriers ntaylor Mon, 02/07/2022 – 05:52 More: Moffitt Dyves back into tumor pH modulation, turning to transdermal delivery to bypass oral barriers Source: fierce
read moreCelltrion races inhaled COVID-19 antibody therapy into phase 3 to counter omicron ntaylor Mon, 02/07/2022 – 05:47 More: Celltrion races inhaled COVID-19 antibody therapy into phase 3 to counter omicron Source: fierce
read moreSanofi’s Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for a rare blood disorder kdunleavy Fri, 02/04/2022 – 16:56 More: Sanofi's Enjaymo, once a jewel in its Bioverativ buyout, finally wins its FDA nod for
read moreRegeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it kdunleavy Fri, 02/04/2022 – 11:00 More: Regeneron projects no near-term sales of its blockbuster COVID-19 antibody given FDA action to ground it Source: fierce
read moreThe hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes fkansteiner Fri, 02/04/2022 – 10:58 More: The hits keep coming: Biogen's Aduhelm marketing, approval under fire in new FTC and SEC probes Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals